Literature DB >> 20626825

Systemic photosensitivity due to a contraceptive patch.

Silvia Gómez-Bernal1, Manuel Loureiro, María Teresa Rodríguez-Granados, Jaime Toribio.   

Abstract

Hormonal contraceptives are a known but rarely reported cause of photosensitivity. A 35-year-old female developed several episodes of a prurigionous papulovesicular eruption located on sun-exposed areas that resolved without scarring in days. She had been using a transdermal contraceptive (EVRA: norelgestromin and ethinyloestradiol) for 3 years, and once it was stopped, the patient became asymptomatic. She had another episode after the use of oral contraceptives (YAZ: ethinyloestradiol and drospirenone). The biopsy of the lesions showed a spongiotic dermatitis. Minimal erythema dose was diminished when the patient was using EVRA and YAZ and became normal when they were withdrawn. Phototesting with UVA, photopatch testing and blood porphyrins were normal. Antinuclear antibodies were 1/80 initially and were 1/320 6 months later. Anti-deoxyribonucleic acid antibodies, extractable nuclear antigens, anti Ro and Anti La were negative and no systemic symptoms had developed. When all hormonal contraceptives were stopped, the patient became asymptomatic. We report a case of systemic photosensitivity induced by the contraceptive patch. To the best of our knowledge, no other cases induced by transdermal contraceptives have been reported previously.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626825     DOI: 10.1111/j.1600-0781.2010.00517.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  2 in total

Review 1.  Drug-induced photosensitivity: culprit drugs, management and prevention.

Authors:  Aaron M Drucker; Cheryl F Rosen
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

2.  Sex hormones and the risk of keratinocyte cancers among women in the United States: A population-based case-control study.

Authors:  Lawrence F Kuklinski; Michael S Zens; Ann E Perry; Anala Gossai; Heather H Nelson; Margaret R Karagas
Journal:  Int J Cancer       Date:  2016-04-15       Impact factor: 7.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.